# Lamisil AT

NDC: 84485-3605
Generic name: terbinafine hydrochloride
Labeler / Manufacturer: Karo Healthcare Inc.
Product type: HUMAN OTC DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SPRAY
Routes: TOPICAL
Marketing started: 20251210

FDA application: NDA021124

## Active ingredients

- TERBINAFINE HYDROCHLORIDE: 1 g/100g

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"84485-3605"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=84485-3605
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21f1bf77-4338-4b75-b513-80a0d98a722a